Predictive Oncology Inc. (POAI) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.65M | -3.32M | -756.35K | -3.04M | -2.28M | -3.22M | -3.42M | -3.08M | -3.1M | -3.57M | -3.43M | -3.23M |
| Operating CF Margin % | -45708.21% | -123931.47% | -685.66% | -497.41% | -659.42% | -1154.57% | -814.02% | -920.02% | -458.89% | -729.28% | -1428.86% | -890.02% |
| Operating CF Growth % | 27.45% | -3.29% | 77.86% | 1.31% | 26.59% | 9.97% | 0.34% | 4.72% | -14.66% | -7.2% | -10.8% | 13.6% |
| Net Income | -77.65M | -1.98M | -2.29M | -2.1M | -2.28M | -3.18M | -3.56M | -3.48M | -3.16M | -3.92M | -3.42M | -7.92M |
| Depreciation & Amortization | 174.59K | 170.25K | 166.07K | 40.06K | 39.8K | 164.16K | 151.25K | 158.34K | 162.99K | 180.13K | 237.85K | 332.69K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 95.77K | 111.26K | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -95.77K | -111.26K | 0 | 0 | 0 |
| Other Non-Cash Items | 74.87M | -639.06K | 229.49K | 1.29M | -1.08M | 119.41K | -705.55K | 95.04K | 107.8K | 229.64K | 20.35K | 3.65M |
| Working Capital Changes | 947.61K | -876.14K | 1.13M | -2.27M | 1.04M | -320.36K | 702.38K | 139.61K | -212.33K | -60.68K | -264.16K | 696.45K |
| Change in Receivables | -3.05K | 36.87K | -25.67K | -281.73K | -132.85K | 122.41K | 49.26K | 211.06K | -113.91K | -148.09K | 48.43K | -6.49K |
| Change in Inventory | 4.72K | 3.05K | 0 | 118.65K | 50.26K | -126.5K | -1.61K | -54.38K | -46.29K | -13.41K | 50.2K | 63.23K |
| Change in Payables | 1.37M | 341.84K | 169.96K | 997 | -413.14K | -159.63K | 414.42K | 173.8K | 158.66K | -265.22K | 331.33K | 26.18K |
| Cash from Investing | 0 | 0 | 625K | 32K | 0 | -6.48K | -3.03K | 7.29K | -3.92K | -259.1K | -46.64K | -63.6K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -6.48K | -3.03K | 7.29K | -3.92K | -255.36K | -24.37K | -57.95K |
| CapEx % of Revenue | 0.08% | 0.07% | 0% | 0% | 0% | 2.32% | 0.72% | 2.18% | 0.58% | 52.1% | 10.16% | 15.94% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 625K | 32K | 0 | 0 | 0 | 0 | 0 | -3.74K | -22.27K | -5.65K |
| Cash from Financing | 1.33M | 726.91K | 2.5M | -195.78K | 888.28K | 3.36M | -112.37K | -111.32K | 260.22K | 0 | 0 | -23.63K |
| Debt Issued (Net) | -76.67K | 264.05K | 0 | -195.78K | -79.32K | 237.06K | -112.37K | -109.81K | 260.22K | 0 | 0 | 0 |
| Equity Issued (Net) | 1000K | 462.86K | 1000K | 0 | 967.6K | 1000K | 0 | -1.51K | 0 | 0 | 0 | -23.63K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -794 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.51K | 0 | 0 | 0 | -23.63K |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 794 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -324.41K | -2.58M | 2.35M | -2.34M | -2.25M | 134.53K | -3.53M | -3.19M | -2.85M | -3.83M | -3.47M | -3.32M |
| Free Cash Flow | -1.65M | -3.32M | -756.35K | -3.04M | -2.28M | -3.22M | -3.42M | -3.08M | -3.11M | -3.83M | -3.47M | -3.3M |
| FCF Margin % | -45708.13% | -123931.39% | -685.66% | -497.41% | -659.42% | -1156.9% | -814.75% | -917.84% | -459.47% | -782.15% | -1448.3% | -907.52% |
| FCF Growth % | 27.45% | -3.08% | 77.88% | 1.07% | 26.68% | 15.88% | 1.59% | 6.78% | -9.61% | -8.83% | -9.47% | 16.28% |
| FCF per Share | -2.28 | -0.36 | -0.11 | -0.56 | -0.36 | -0.69 | -0.84 | -0.76 | -0.77 | -0.96 | -0.88 | -0.84 |
| FCF Conversion (FCF/Net Income) | 0.02x | 1.61x | 0.31x | 1.40x | 0.74x | 1.01x | 0.81x | 0.89x | 0.98x | 0.91x | 1.00x | 0.41x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |